AHA GUIDELINES Bundle (free trial)

Dyslipidemia 2026

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1543908

Contents of this Issue

Navigation

Page 37 of 105

38 Management 4.2.3.4. Reproductive Risk Markers COR LOE Recommendation 2a B-NR 1. In adults without ASCVD, consideration of reproductive risk markers, such as early menopause (<45 years) and history of adverse pregnancy outcomes (gestational hypertension, preeclampsia, gestational diabetes, preterm delivery) is reasonable to personalize ASCVD risk assessment when considering the potential benefit of initiating LLT as an adjunct to lifestyle management for primary ASCVD prevention. Table 14. Reproductive Risk Markers Associated With ASCVD Events Adverse Pregnancy Outcomes* That Have a Stronger Association With ASCVD Events • Hypertensive disorders of pregnancy (preeclampsia, gestational hypertension) • Gestational diabetes • Small-for-gestational age (birthweight below the 10th percentile) • Preterm delivery (before 37 weeks' gestation) • Recurrent spontaneous pregnancy loss Other Reproductive Risk Markers • Early menarche (<10 y old) • Early menopause (<45 y old), especially premature menopause (<40 y old) • Polycystic ovarian syndrome and irregular menses * See reference for a full list of Adverse Pregnancy Outcomes. ASCVD indicates atherosclerotic cardiovascular disease; and y, years.

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Dyslipidemia 2026